Professional Documents
Culture Documents
Indication: Before: Drug MOA Indication C/I Common Side Effects: NX Consideration Generic Name: Baseline Assessment
Indication: Before: Drug MOA Indication C/I Common Side Effects: NX Consideration Generic Name: Baseline Assessment
FREQUENCY: AFTER
N/A PATIENT/FAMILY
TEACHING:
ROUTE: -Discontinue drug if
N/A pain is still present
after multiple intake